#United States #Biopharma #Deerfield #Veeva #Zifo

Veeva and Zifo Partner to Revolutionize Quality Control in Biopharmaceuticals

In a significant move for the biopharmaceutical sector, Veeva Systems (NYSE: VEEV) has announced a strategic partnership with Zifo to modernize quality control (QC) operations. This collaboration aims to streamline the quality management processes that are critical to the life sciences industry, and it promises to alleviate some of the burdens associated with legacy systems.

The Vision Behind the Partnership

The core of the partnership revolves around the integration of Veeva's Laboratory Information Management System (LIMS) with Zifo's data integration and management platform, known as qcKen. This innovative alignment allows biopharma companies to import data from any source document directly into Veeva LIMS. The outcome? A reduction in the complexities involved in master data configuration during the implementation of LIMS and site deployment, ultimately allowing organizations to move on from outdated QC methodologies.

Kannan Jagamoorthy, the general manager and head of Zifo North America, expressed his enthusiasm for this partnership, stating, "We are excited to partner with Veeva to offer powerful solutions to the life sciences industry. Our collaboration will help customers expedite their adoption of Veeva LIMS to streamline operations."

Benefits of the Integration

The merger of these two platforms aims to enhance how biopharmaceutical companies handle their quality assurance (QA) and QC processes. Veeva takes a comprehensive approach to these operations, ensuring they support Good Manufacturing Practice (GMP) quality business processes with improved accuracy. The utilization of Zifo's qcKen is expected to facilitate faster creation of test and specification data, streamline implementations and site deployments, and ultimately provide a quicker return on investment for companies opting for Veeva LIMS.

Ashley McMillan, senior director of Veeva LIMS strategy, emphasized the advantages of this partnership, stating, "Veeva LIMS is geared for life sciences organizations looking to enhance their QC operations and speed up batch release cycles. Partnering with Zifo enables our customers to implement Veeva LIMS more swiftly, maximizing the value derived from QC modernization initiatives."

The Role of Cloud Technology

An additional layer of transformation comes from the integration’s cloud-based environment. By leveraging a unified cloud LIMS, biopharmaceutical companies are well-positioned to improve their 'right first time' metrics and accelerate batch release processes, which are critical in a highly regulated industry where delays can result in significant financial losses and regulatory challenges.

Zifo’s formal recognition as a Veeva Product Partner enhances its already established status as a Veeva Services Partner, confirming the integral role it will play in helping clients meet their digital transformation goals.

About Veeva and Zifo

Veeva Systems is recognized as the global leader in cloud software tailored for the life sciences sector. Serving a clientele of more than 1,000 customers—from the largest biopharmaceutical companies to emerging biotech firms—Veeva is focused on product innovation and customer success. The company also stands out as a Public Benefit Corporation, ensuring that the interests of all stakeholders—customers, employees, and shareholders—are taken into account.

On the other hand, Zifo excels in enabling AI and data-driven enterprise informatics for science-driven organizations. With expertise spanning research, development, manufacturing, and clinical domains, Zifo serves a broad spectrum of industries including pharmaceuticals, biotech, chemicals, and food and beverage. Trusted by over 190 science-focused organizations globally, Zifo is seen as a vital partner for fostering digital scientific innovation.

In conclusion, this partnership between Veeva and Zifo marks a pivotal step towards enhancing quality control processes in biopharma. By allowing for more streamlined operations and an accelerated transition to modern QC systems, these two companies are not only driving industry innovation but also reshaping the future of life sciences operations worldwide.